Is ESBL E. coli resistance in UTIs a local cluster or broader trend?

[HannahW]

I'm a medical laboratory scientist, and we've been seeing an unusual pattern of antibiotic resistance in urinary tract infection isolates over the last quarter, with several ESBL-producing E. coli strains showing resistance to our usual first-line treatments. I'm trying to understand if this is a local cluster or part of a broader trend. For others working in clinical or medical microbiology, what surveillance tools or databases do you find most effective for tracking regional resistance patterns? How does your lab approach communicating these shifts to clinicians to guide empirical therapy, and are there specific molecular methods beyond standard culture and sensitivity that you've implemented for faster detection of resistance mechanisms?